Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States

Citation
Wc. Chang et al., Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States, CAN J CARD, 16(10), 2000, pp. 1231-1239
Citations number
48
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
CANADIAN JOURNAL OF CARDIOLOGY
ISSN journal
0828282X → ACNP
Volume
16
Issue
10
Year of publication
2000
Pages
1231 - 1239
Database
ISI
SICI code
0828-282X(200010)16:10<1231:TEITMO>2.0.ZU;2-W
Abstract
BACKGROUND: Temporal changes in baseline characteristics, treatment and cli nical outcomes of patients presenting with acute ST elevation myocardial in farction in Canada and the United States have not been examined comprehensi vely over time. OBJECTIVES: To evaluate baseline characteristics, process of care and clini cal outcomes. Also, to explore whether earlier process-of-care differences between Canada and the United States had changed and, if so, whether they i nfluenced clinical outcomes. PATIENTS AND METHODS: A total of 13,888 American and 3011 Canadian patients enrolled in 184 American and 38 Canadian hospitals that participated in bo th the Global Utilization of Streptokinase and Tissue Plasminogen Activator (alteplase) for Occluded Coronary Arteries (GUSTO-I) trial (1990 to 1993) and the Global Utilization of Strategies to Open Occluded Coronary Arteries (GUSTO-III) trial (1995 to 1997) were studied. Logistic regression was use d to identify significant prognostic factors, to assess illness severity at hospital presentation and to classify trends between Canada and the United States. RESULTS: In both countries, illness severity on admission increased, door-t o-needle time for thrombolysis was reduced, intensive care unit stay was sh ortened and hospital stay decreased from GUSTO-I to GUSTO-III. Whereas the administration of oral nitrates, calcium blockers and beta blockers at disc harge converged over time between countries, the disparity in the use of an giography and revascularization widened; the rise in American revasculariza tion rate was most evident in patients without in-hospital ischemia. The 30 -day and one-year mortality rates were comparable and declined nonsignifica ntly in both countries. CONCLUSIONS: Despite increased illness severity and varying medication and procedure rates, there was no increase over time in 30-day or one-year mort ality; this remained comparable between countries throughout the seven-year observation period.